Open Orphan – Positive Phase 1 study results published in The Lancet June 15, 2020 – Posted in: Open Orphan (ORPH)

Monday 15th June, 2020 Open Orphan plc (“Open Orphan” or the “Company”) Positive Phase I study results published in The Lancet Positive results from the Phase I study of the AGS-v vaccine developed by an Open Orphan joint venture, Imutex Limited, have been published in the peer reviewed journal The Lancet AGS-v is a first-in-class mosquito saliva, standalone, vaccine candidate designed to protect against mosquito-borne diseases carried in the saliva such as Zika, Malaria, Dengue Fever and…

Continue reading